Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 500 of 984 entries
View as:

Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01972724 Org: User:
Start: 12/16/13 End: 10/17/16 Due: 10/17/17

Norwalk Vaccine Study

Phase: N/A Priority: Normal
NCT ID: NCT00973284 Org: User:
Start: 08/04/09 End: 08/18/10 Due: 08/18/11

A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids

Phase: N/A Priority: Normal
NCT ID: NCT02655224 Org: User:
Start: 03/26/16 End: 05/19/17 Due: 05/19/18

A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935

Phase: N/A Priority: Normal
NCT ID: NCT02497235 Org: User:
Start: 07/31/15 End: 01/31/16 Due: 01/31/17

Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)

Phase: N/A Priority: Normal
NCT ID: NCT01456260 Org: User:
Start: 09/30/11 End: 12/31/13 Due: 12/31/14

A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT03316976 Org: User:
Start: 11/22/17 End: 02/08/18 Due: 02/08/19

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01677182 Org: User:
Start: 08/31/12 End: 09/30/14 Due: 09/30/15

Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids

Phase: N/A Priority: Normal
NCT ID: NCT01452659 Org: User:
Start: 10/31/11 End: 09/30/12 Due: 09/30/13

Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension Study

Phase: N/A Priority: Normal
NCT ID: NCT01152996 Org: User:
Start: 09/30/10 End: 05/31/13 Due: 05/31/14

A Post-Marketing Surveillance Study on NesinaAct® Tablet Use Among Type 2 Diabetes Mellitus Participants in Korea

Phase: N/A Priority: Normal
NCT ID: NCT04980014 Org: User:
Start: 10/02/15 End: 08/30/19 Due: 08/30/20

A Real World Study of Mobocertinib in Adults With Lung Cancer in China (MEANING)

Phase: N/A Priority: Normal
NCT ID: NCT05863819 Org: User:
Start: 03/30/24 End: 02/01/27 Due: 02/01/28

A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

Phase: N/A Priority: Normal
NCT ID: NCT05714969 Org: User:
Start: 03/21/23 End: 06/11/26 Due: 06/11/27

Efficacy and Safety of Coumarin and Troxerutin in the Symptomatic Treatment of Chronic Venous Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT01848210 Org: User:
Start: 05/31/13 End: 09/30/15 Due: 09/30/16

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose and Multiple Doses With Titration of TAK-935 in Healthy Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT04461483 Org: User:
Start: 08/13/20 End: 11/14/20 Due: 11/14/21

Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01122121 Org: User:
Start: 03/31/00 End: 06/30/09 Due: 06/30/10

A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT04278924 Org: User:
Start: 11/09/20 End: 04/29/24 Due: 04/29/25

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT02158364 Org: User:
Start: 03/28/07 End: 02/20/11 Due: 02/20/12

Survey Study for Velaglucerase Alfa (VPRIV) in Japan

Phase: N/A Priority: Normal
NCT ID: NCT03625882 Org: User:
Start: 09/02/14 End: 05/14/24 Due: 05/14/25

Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT01609582 Org: User:
Start: 06/30/12 End: 05/31/14 Due: 05/31/15

A Study of Prucalopride For Functional Constipation in Children and Teenagers

Phase: N/A Priority: Normal
NCT ID: NCT04759833 Org: User:
Start: 07/13/21 End: 11/13/23 Due: 11/13/24

Phase 1, Febuxostat XR Relative Bioavailability Study

Phase: N/A Priority: Normal
NCT ID: NCT02504320 Org: User:
Start: 08/31/15 End: 10/31/15 Due: 10/31/16

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

Phase: N/A Priority: Normal
NCT ID: NCT06165341 Org: User:
Start: 03/01/24 End: 08/26/28 Due: 08/26/29

Ramelteon in Adults With Chronic Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00671567 Org: User:
Start: 12/31/02 End: 09/30/03 Due: 09/30/04

Phase 1, TAK-648, Single-Rising Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT02684396 Org: User:
Start: 08/31/14 End: 07/31/15 Due: 07/31/16

A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT02713061 Org: User:
Start: 03/31/16 End: 04/30/16 Due: 04/30/17